SPM 927
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for SPM 927, covering 2009-10-05 to 2024-04-19. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN). [Phase 2]